| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | BIOTECNOLOGÍA | 55,183329 | 29/04/2025 | -15,18% | -27,10% | * |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | BIOTECNOLOGÍA | 53,940000 | 29/04/2025 | -15,59% | -27,32% | * |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 53,230000 | 29/04/2025 | -9,30% | -25,30% | * |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) EUR | MIXTO AGRESIVO GLOBAL | 116,420000 | 29/04/2025 | -6,18% | 7,48% | **** |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) USD | MIXTO AGRESIVO GLOBAL | 116,688649 | 29/04/2025 | -5,78% | 7,55% | **** |
| JPM TOTAL EMERGING MARKETS INCOME A (DIST) EUR | MIXTO AGRESIVO GLOBAL | 86,250000 | 29/04/2025 | -6,18% | -2,48% | * |
| JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | MIXTO AGRESIVO GLOBAL | 89,170000 | 29/04/2025 | -7,49% | -9,07% | * |
| JPM TOTAL EMERGING MARKETS INCOME C (ACC) EUR | MIXTO AGRESIVO GLOBAL | 131,330000 | 29/04/2025 | -5,95% | 9,91% | ***** |
| JPM TOTAL EMERGING MARKETS INCOME D (ACC) EUR | MIXTO AGRESIVO GLOBAL | 107,950000 | 29/04/2025 | -6,37% | 5,39% | *** |
| JPM TOTAL EMERGING MARKETS INCOME D (ACC) USD | MIXTO AGRESIVO GLOBAL | 108,291568 | 29/04/2025 | -5,98% | 5,48% | *** |
